Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5δ32) and normal human lymphoid tissue

Virology

Volumn 281, Issue 2, 2001, Pages 239-247

  Malkevitch, Nina ^a   McDermott, David H ^b   Yi, Yanjie ^c   Grivel, Jean Charles ^a   Schols, Dominique ^d   De Clercq, Erik ^d   Murphy, Philip M ^b   Glushakova, Svetlana ^a   Collman, Ronald G ^c   Margolis, Leonid ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

AMD3100; CCR5; Chemokine receptor; CXCR4; HIV; Pathogenesis; RANTES; T lymphocytes

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RANTES;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035866610     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0807     Document Type: Article

References (41)

1. A new classification for HIV-1
2. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism and disease
3. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
4. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection
5. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1
6. Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals
7. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5
8. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
9. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co- receptor
10. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
11. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
12. Infection of human tonsil histocultures: A model for HIV pathogenesis
13. + T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histoculture inoculated with laboratory strains and patient isolates of HIV type 1
14. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency
15. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo
16. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue
17. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
18. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
19. CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: Role of signal transduction
20. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
21. CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptor
22. HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation
23. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
24. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS
25. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines
26. Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry
27. International union of pharmacology. XXII. Nomenclature for chemokine receptors
28. Utilization of chemokine receptors, orphan receptors, and herpesvirus- encoded receptors by diverse human and simian immunodeficiency viruses
29. Molecular cloning and functional expression of a new human CC-chemokine receptor gene
30. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
31. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
32. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
33. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry
34. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate
35. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality
36. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
37. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
38. Constitutive cell surface association between CD4 and CCR5
39. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells
40. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
41. Genotypic and phenotypic characterization of HIV-1 patients with primary infection